Mini-reviews micrornas:novel biomarkers for human cancer

Clinical Chemistry

Volumn 55, Issue 4, 2009, Pages 623-631

  Bartels, Claudine L ^a   Tsongalis, Gregory J ^a,b  

^a NORRIS COTTON CANCER CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; TUMOR MARKER;

BREAST CANCER; CANCER INVASION; CANCER TISSUE; CHRONIC LYMPHATIC LEUKEMIA; COLORECTAL CANCER; DISEASE COURSE; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE TARGETING; GENOME ANALYSIS; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; METASTASIS; MICROARRAY ANALYSIS; PANCREAS CANCER; PROGNOSIS; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA DEGRADATION; RNA STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION; TISSUE LEVEL; TISSUE SPECIFICITY; TRANSLATION REGULATION; TREATMENT RESPONSE; TUMOR GENE; ANIMAL; CHEMISTRY; CONFORMATION; DIAGNOSTIC PROCEDURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; REVIEW;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASMS; NUCLEIC ACID CONFORMATION; TUMOR MARKERS, BIOLOGICAL;

EID: 64149132942     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.112805     Document Type: Short Survey

References (79)

1. Kulasingam V, Diamandis EP. Strategies for dis- covering novel cancer biomarkers through utili- zation of emerging technologies. Nat Clin Pract Oncol 2008;5:588-99.
2. Bentwich I. Prediction and validation of microRNAs and their targets. FEBS Lett 2005;579:5904-10.
3. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers [see comment]. Nature 2005;435:834-8.
4. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, et al. MicroRNAs accu- rately identify cancer tissue origin. Nat Biotechnol 2008;26:462-9.
5. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004;23:4051-60.
6. Borchert GM, Lanier W, Davidson BL. RNA poly- merase III transcribes human microRNAs. Nat Struct Mol Biol 2006;13:1097-101.
7. Lee Y, Han J, Yeom KH, Jin H, Kim VN. Drosha in primary microRNA processing. Cold Spring Harb Symp Quant Biol 2006;71:51-7.
8. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R. The Micro- processor complex mediates the genesis of microRNAs. Nature 2004;432:235-40.
9. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Sci- ence 2004;303:95-8.
10. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003;425:415-9.
11. Lee Y, Jeon K, Lee JT, Kim S, Kim NV. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002;21:4663-70.
12. Hutvagner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002;297:2056-60.
13. Brennecke, J, Stark A, Russell RB, Cohen SB. Principles of microRNA-target recognition. PLoS Biol 2005;3:e85.
14. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA se- quences, targets and gene nomenclature. Nucleic Acids Res 2006;34:D140-4.
15. Ambros V, Bartel B, Bartel DP, Burge CB, Car- rington JC, Chen X, et al. A uniform system for microRNA annotation. RNA 2003;9:277-9.
16. Petersen M, Nielsen CB, Nielsen KE, Jensen GA, Bondensgaard K, Singh SK, et al. The conforma- tions of locked nucleic acids (LNA). J Mol Recog- nit 2000;13:44-53.
17. Valoczi A, Hornyik C, Varga N, Burgyan J, Kaup- pinen S, Havelda Z. Sensitive and specific detec- tion of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes. Nucleic Ac- ids Res 2004;32:e175.
18. Luminex. FlexmiR MicroRNA Human Panel in- structions. http://www.luminexcorp.com/(Ac- cessed September 2008).
19. Schmittgen TD, Lee EJ, Jiang J, Sarkar A, Yang L, Elton TC, et al. Real-time PCR quantification of precursor and mature microRNA. Methods 2008; 44:31-8.
20. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics. CA Cancer J Clin 2008;58: 71-96.
21. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005;65:7065-70.
22. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA- 10b in breast cancer. Nature 2007;449:682-8.
23. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, et al. The microRNAs miR-373 and miR-520c promote tumour invasion and me- tastasis. Nat Cell Biol 2008;10:202-10.
24. Diaz LK, Zhou X, Wright ET, Cristofanilli M, Smith T, Yang Y, et al. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma. Clin Cancer Res 2005;11: 3309-14.
25. Frankel LB, Christoffersen NR, Jacobsen A, Lin- dow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008;283:1026-33.
26. Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007;282:14328-36.
27. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21- mediated tumor growth. Oncogene 2007;26: 2799-803.
28. Schmid T, Jansen AP, Baker AR, Hegamyer G, Hagan JP, Colburn NH. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Res 2008;68:1254-60.
29. Perry SV. Vertebrate tropomyosin: distribution, properties and function. J Muscle Res Cell Motil 2001;22:5-49.
30. Hossain A, Kuo MT, Saunders GF. Mir-17-5p regulates breast cancer cell proliferation by inhib- iting translation of AIB1 mRNA. Mol Cell Biol 2006;26:8191-201.
31. Eiriksdottir G, Johannesdottir G, Ingvarsson S, Bjornsdottir IB, Jonasson JG, Agnarsson BA, et al. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Eur J Cancer 1998;34:2076-81.
32. Louie MC, Zou JX, Rabinovich A, Chen HW. ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol Cell Biol 2004;24:5157-71.
33. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, et al. AIB1, a steroid receptor coactivator amplified in breast and ovar- ian cancer. Science 1997;277:965-8.
34. Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M, et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Bio 2008;182:509-17.
35. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metasta- sis. Nature 2008;451:147-52.
36. Adams BD, Furneaux H, White BA. The micro- ribonucleic acid (miRNA) miR-206 targets the hu- man estrogen receptor- (ER) and represses ER messenger RNA and protein expression in breast cancer cell lines. J Mol Endocrinol 2007; 21:1132-47.
37. Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H. miR-206 expression is down-regulated in es- trogen receptor -positive human breast cancer. Cancer Res 2008;68:5004-8.
38. Wang M, Tan LP, Dijkstra MK, van Lom K, Rob- ertus JL, Harms G, et al. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation cen- tres characterized by low miR-150 and high BIC/miR-155 expression. J Pathol 2008;215:13-20.
39. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, et al. A microRNA signa- ture associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005;353:1793-801;
40. Erratum 2006;355:533.
41. Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, Tavolaro S, et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 2007;109:4944-51.
42. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A, 2005;102:3627-32.
43. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferra- cin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005;102:13944-9;
44. Erratum 2006;103:2464.
45. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, et al. miR-15a and miR- 16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A 2008;105:5166-71.
46. Pekarsky Y, Santanam U, Cimmino A, Palamar- chuk A, Efanov A, Maximov V, et al. Tcl1 expres- sion in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006;66: 11590-3.
47. Marton S, Garcia MR, Robello C, Persson H, Tra- jtenberg F, Pritsch O, et al. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia 2008;22:330-8.
48. Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T. Downregulation of microRNAs-143 and 145 in B-cell malignancies. Cancer Sci 2007;98:1914-20.
49. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, et al. The colorectal microRNAome. Proc Natl Acad Sci U S A 2006;103:3687-92.
50. Nagel R, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A, et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 2008;68: 5795-802.
51. Michael MZ, O» Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003;1:882-91.
52. Akao Y, Nakagawa Y, Naoe T. MicroRNA-143 and 145 in colon cancer. DNA Cell Biol 2007; 26:311-20.
53. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD, Guda K. The noncoding RNA, miR-126, sup- presses the growth of neoplastic cells by target- ing phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromo- somes Cancer 2008;47:939-46.
54. Bandrés E, Cubedo E, Agirre X, Malumbres R, Zárate R, Ramirez N, et al. Identification by real- time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006;5:29.
55. Lanza G, Ferracin M, Gafa R, Veronese A, Spizzo R, Pichiorri F, et al. mRNA/microRNA gene ex- pression profile in microsatellite unstable colorec- tal cancer. Mol Cancer 2007;6:54.
56. Bruix J, Sherman M. American Association for the Study of Liver Diseases practice guideline. Man- agement of hepatocellular carcinoma. Hepatol- ogy 2008;42:1208-36.
57. Lencioni R, Cioni D, Della Pina C, Crocetti L, Bartolozzi C. Imaging diagnosis. Semin Liver Dis 2005;25:162-70.
58. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, et al. Comprehensive anal- ysis of microRNA expression patterns in hepato- cellular carcinoma and non-tumorous tissues. On- cogene 2006;25:2537-45.
59. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, et al. MicroRNA profil- ing in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008;47:1955-63.
60. Li W, Xie L, He X, Li J, Tu K, Wei L, et al. Diagnostic and prognostic implications of micro- RNAs in human hepatocellular carcinoma. Int J Cancer 2008;123:1616-22.
61. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, et al. Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Can Res 2008;14:419-27.
62. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, et al. miR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in hu- man hepatocellular carcinoma. Oncogene 2008; 27:5651-61.
63. Meyerson M, Carbone D. Genomic and proteomic profiling of lung cancers: lung cancer classifica- tion in the age of targeted therapy. J Clin Oncol 2005;23:3219-26.
64. Granville CA, Dennis PA. An overview of lung cancer genomics and proteomics. Am J Respir Cell Mol Biol 2005;32:169-76.
65. Roush S, Slack FJ. The let-7 family of microRNAs. Trends Cell Biol 2008;18:505-16.
66. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis A, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell 2005;120:635-47.
67. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A 2008;105: 3903-8.
68. Weiss GJ, Bemis LT, Nakajima E, Sugita M, Birks DK, Robinson WA, et al. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR ex- pression in cell lines. Ann Oncol 2008;19:1053-9.
69. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, et al. MicroRNA signature predicts sur- vival and relapse in lung cancer. Cancer Cell 2008;13:48-57.
70. Garcea G, Neal CP, Pattenden CJ, Steward WP, Berry DP. Molecular prognostic markers in pan- creatic cancer: a systematic review. Eur J Cancer 2005;41:2213-36.
71. Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005; 11:241-7.
72. Shingara J, Keiger K, Shelton J, Laosinchai-Wolf W, Powers P, Conrad D, et al. An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 2005;11: 1461-70.
73. Sood P, Krek A, Zavolan M, Macino G, Rajewsky N. Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci U S A, 2006;103:2746-51.
74. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, et al. MicroRNA expression alterations are linked to tumorigenesis and non- neoplastic processes in pancreatic ductal adeno- carcinoma. Oncogene 2007;26:4442-52.
75. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, et al. MicroRNA expression patterns to differentiate pancreatic adenocarci- noma from normal pancreas and chronic pancre- atitis. JAMA 2007;297:1901-8.
76. Szafranska AE, Doleshal M, Edmunds HS, Gordon S, Luttges J, Munding JB, et al. Analysis of mi- croRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem 2008;54:1716-24.
77. Shi XB, Tepper CG, White RW. MicroRNAs and prostate cancer. J Cell Mol Med 2008;12: 1456-65.
78. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TLJ, Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Res 2007;67: 6130-5.
79. Ozen M, Creighton CJ, Ozdemir M, Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 2008;27: 1788-93.